BMRA
Income statement / Annual
Last year (2024), Biomerica, Inc.'s total revenue was $5.42 M,
an increase of 1.42% from the previous year.
In 2024, Biomerica, Inc.'s net income was -$5.98 M.
See Biomerica, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
05/31/2024 |
05/31/2023 |
05/31/2022 |
05/31/2021 |
05/31/2020 |
05/31/2019 |
05/31/2018 |
05/31/2017 |
05/31/2016 |
05/31/2015 |
Operating Revenue |
$5.42 M
|
$5.34 M
|
$18.87 M
|
$7.20 M
|
$6.69 M
|
$5.20 M
|
$5.56 M
|
$5.79 M
|
$5.14 M
|
$4.96 M
|
Cost of Revenue |
$4.80 M |
$4.89 M |
$15.89 M |
$6.70 M |
$4.91 M |
$3.91 M |
$3.81 M |
$3.77 M |
$3.62 M |
$3.42 M |
Gross Profit |
$611,000.00 |
$446,000.00 |
$2.98 M |
$496,981.00 |
$1.78 M |
$1.29 M |
$1.75 M |
$2.02 M |
$1.52 M |
$1.54 M |
Gross Profit Ratio |
0.11 |
0.08 |
0.16 |
0.07 |
0.27 |
0.25 |
0.32 |
0.35 |
0.3 |
0.31 |
Research and Development
Expenses |
$1.49 M
|
$1.58 M
|
$1.81 M
|
$2.41 M
|
$1.91 M
|
$1.68 M
|
$1.40 M
|
$1.13 M
|
$780,333.00
|
$733,640.00
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$14,613.00
|
$0.00
|
$0.00
|
$0.00
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1,223.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$5.49 M
|
$6.09 M
|
$5.70 M
|
$4.61 M
|
$2.27 M
|
$2.03 M
|
$1.84 M
|
$1.85 M
|
$1.57 M
|
$1.48 M
|
Other Expenses |
$0.00 |
$1,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$7,009.00 |
$2,255.00 |
Operating Expenses |
$6.98 M |
$7.67 M |
$7.51 M |
$7.02 M |
$4.18 M |
$3.70 M |
$3.24 M |
$2.98 M |
$2.35 M |
$2.21 M |
Cost And Expenses |
$11.78 M |
$12.56 M |
$23.41 M |
$13.72 M |
$9.10 M |
$7.61 M |
$7.05 M |
$6.75 M |
$5.97 M |
$5.63 M |
Interest Income |
$431,000.00 |
$133,000.00 |
$26,639.00 |
$66,863.00 |
$71,193.00 |
$44,014.00 |
$47,764.00 |
$46,354.00 |
$24,123.00 |
$21,906.00 |
Interest Expense |
$0.00 |
$0.00 |
$26,639.00 |
$367.00 |
$9.00 |
$47.00 |
$37.00 |
$282.00 |
$167.00 |
$0.00 |
Depreciation &
Amortization |
$374,000.00
|
$351,000.00
|
$594,821.00
|
$375,855.00
|
$398,632.00
|
$162,905.00
|
$186,601.00
|
$219,219.00
|
$232,422.00
|
$253,275.00
|
EBITDA |
-$5.99 M
|
-$6.74 M
|
-$3.94 M
|
-$7.06 M
|
-$2.27 M
|
-$2.21 M
|
-$1.25 M
|
-$689,340.00
|
-$563,567.00
|
-$393,154.00
|
EBITDA Ratio |
-1.11 |
-1.29 |
-0.21 |
-0.84 |
-0.29 |
-0.42 |
-0.22 |
-0.12 |
-0.11 |
-0.08 |
Operating Income Ratio
|
-1.18
|
-1.35
|
-0.24
|
-0.91
|
-0.36
|
-0.46
|
-0.27
|
-0.16
|
-0.16
|
-0.14
|
Total Other
Income/Expenses Net |
$431,000.00
|
$134,000.00
|
$26,639.00
|
$66,496.00
|
$71,184.00
|
$43,967.00
|
$47,727.00
|
$46,072.00
|
$30,965.00
|
$24,161.00
|
Income Before Tax |
-$5.94 M |
-$7.09 M |
-$4.51 M |
-$6.46 M |
-$2.33 M |
-$2.37 M |
-$1.43 M |
-$908,561.00 |
-$795,987.00 |
-$646,434.00 |
Income Before Tax Ratio
|
-1.1
|
-1.33
|
-0.24
|
-0.9
|
-0.35
|
-0.46
|
-0.26
|
-0.16
|
-0.15
|
-0.13
|
Income Tax Expense |
$42,000.00 |
$51,000.00 |
$23,719.00 |
$13,057.00 |
$7,390.00 |
$24,237.00 |
$31,800.00 |
$46,636.00 |
$703,800.00 |
-$315,024.00 |
Net Income |
-$5.98 M |
-$7.14 M |
-$4.53 M |
-$6.47 M |
-$2.34 M |
-$2.39 M |
-$1.47 M |
-$908,561.00 |
-$1.50 M |
-$331,410.00 |
Net Income Ratio |
-1.1 |
-1.34 |
-0.24 |
-0.9 |
-0.35 |
-0.46 |
-0.26 |
-0.16 |
-0.29 |
-0.07 |
EPS |
-0.36 |
-0.5 |
-0.36 |
-0.54 |
-0.23 |
-0.26 |
-0.17 |
-0.11 |
-0.2 |
-0.0439 |
EPS Diluted |
-0.36 |
-0.5 |
-0.36 |
-0.54 |
-0.23 |
-0.26 |
-0.17 |
-0.11 |
-0.2 |
-0.0439 |
Weighted Average Shares
Out |
$16.82 M
|
$14.15 M
|
$12.67 M
|
$11.93 M
|
$10.17 M
|
$9.21 M
|
$8.57 M
|
$8.26 M
|
$7.50 M
|
$7.55 M
|
Weighted Average Shares
Out Diluted |
$16.82 M
|
$14.15 M
|
$12.67 M
|
$11.93 M
|
$10.17 M
|
$9.21 M
|
$8.57 M
|
$8.33 M
|
$7.63 M
|
$7.55 M
|
Link |
|
|
|
|
|
|
|
|
|
|